Article
Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway.
The EMBO journal - 1 Jun 1999
Park J, Leong M L, Buse P, Maiyar A C, Firestone G L, Hemmings B A
Abstract excerpt
Serum and glucocorticoid-inducible kinase (SGK) is a novel member of the serine/threonine protein kinase family that is transcriptionally regulated. In this study, we have investigated the regulatory mechanisms that control SGK activity. We have established a peptide kinase assay for SGK and present evidence demonstrating that SGK is a component of the phosphoinositide 3 (PI 3)-kinase signaling pathway. Treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
